[Travatan--preliminary results].
The prostaglandin analogues represent the first option for the treatment of primary open angle glaucoma. The aim of this paper was to evaluate the efficacy and the safety of Travatan în treatment for different type of glaucoma. It was performed an observational clinical study between November 2002 and March 2003 on 33 patients (62 eyes), who were divided into treatment with Travatan în 4 groups. The reduction of IOP was between 3.80-7.80 mm Hg, with 70.94% complete success (IOP < 18 mm Hg) and qualified success (IOP < 22 mm Hg) în 88.31% cases. Travatan was effective as single therapy or adjunctive therapy, with important and stable lowering IOP. The product was safe, well tolerated and easy for administration.